ABSTRACT
INTRODUCTION

41
The ability of some exogenous chemicals to disrupt normal endocrine function has been 42 well demonstrated. In response, significant efforts are underway to develop screening and 43 testing strategies aimed at detecting and characterizing hazard resulting from exposure to 44 endocrine disrupting chemicals (EDCs). This effort is not trivial. The endocrine system consists 45 of an extensive network of signaling pathways with hundreds of potential targets of disruption.
46
Individual pathways within the network have evolved to respond to different chemical regulators (hormones) and, accordingly, have diverse susceptibilities to exogenous chemicals. Species dietary vitamin D, RAR -dietary vitamin A). Furthermore, the three signaling pathways utilize a 86 common receptor, the retinoid X receptor (RXR), to partner with the primary receptor to form an 87 active dimeric transcription factor. RXR also can serve as an independent, ligand-activated 88 transcription factor.
89
The existence of a common ligand-binding component (RXR) to the three pathways 90 provides a scenario for possible inter-pathway interactions (Fig. 1) . For example, a ligand to 91 RXR may simultaneously activate one signaling pathway, suppress another, and have no effect The provision of two distinct ligand binding sites, one on each receptor protein subunit,
98
within the receptor complex provides the opportunity for intra-pathway interactions between 99 ligand to the primary receptor and ligand to the RXR (Fig. 1) EAT pathways that are well represented within the EPA/OECD endocrine screening programs.
119
The foundation of the discussion was based upon a recent OECD detailed review paper (DRP) 
145
Results from two publications were discussed (Ibhazehiebo et al., 2011 , Iwasaki et al., 2008 146 demonstrating the utility of a NR:HRE association/dissociation assay to inform NR-DNA 147 interactions. Results of assay performance were described in context of specific chemical agents 148 that disrupt TR signaling through this mechanism. A more robust basis for Test Guideline (TG) recommendations, however, is still needed.
276
Although there is evidence to suggest that epigenomic dysregulation might mediate effects of 277 exposures to endocrine disruptors, it is uncertain as to whether these changes are truly predictive Other assays that can evaluate the effects of chemicals on the epigenome, particularly those 312 involving zebrafish, should also be considered as the role of epigenetic modulations becomes an 313 area of increasing importance. In addition, modifications to existing assays to include genomic-and epigenetic-relevant endpoints can further expand the information that can be obtained from 315 animal tissues used in higher level tests.
316
As the number of suggested screening assays increases to address these new potential 317 targets, the need to devise rapid screening methods becomes increasingly important. Thoughtful 318 and strategic utilization of high throughput screening assays in conjunction with alternative 319 models and computational technologies could add significant value to the overall effectiveness of 320 this approach and provide a method for rapidly screening hundreds to thousands of chemicals; 321 and framing these data within the context of adverse outcome pathways will provide the most 322 effective approach in the prioritization of chemicals. Therefore, the utilization of transparent, 323 scientifically sound, and relevant tools to assess these pathways will be key as we move forward 324 in this effort. B.
Figure 2. The rule-based ERESv1 for predicting binding potential for low affinity chemicals to the rtER. The decision tree contains seven major nodes and multiple effects-based chemical categories within the nodes. The ERES is built on rainbow trout ER binding data using the cyto rtERαß in combination with rainbow trout tissue slice gene activation data.
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Figure 3. Current OECD (and related stakeholder activities) Workplan Timeline 
